THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 87 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $27,000 | +170.0% | 48,006 | +102.5% | 0.00% | – |
| Q4 2016 | $10,000 | -37.5% | 23,702 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | -40.7% | 23,702 | -43.5% | 0.00% | – |
| Q2 2016 | $27,000 | +42.1% | 41,984 | 0.0% | 0.00% | – |
| Q1 2016 | $19,000 | -5.0% | 41,984 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | -86.6% | 41,984 | +14.2% | 0.00% | -100.0% |
| Q3 2015 | $149,000 | +684.2% | 36,754 | +680.7% | 0.00% | – |
| Q2 2015 | $19,000 | -62.0% | 4,708 | -61.9% | 0.00% | – |
| Q1 2015 | $50,000 | -2.0% | 12,351 | -23.8% | 0.00% | – |
| Q4 2014 | $51,000 | -12.1% | 16,205 | 0.0% | 0.00% | – |
| Q3 2014 | $58,000 | -37.0% | 16,205 | -30.5% | 0.00% | – |
| Q2 2014 | $92,000 | -17.1% | 23,311 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $111,000 | +2.8% | 23,311 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $108,000 | 0.0% | 23,311 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $108,000 | – | 23,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 270,500 | $1,288,000 | 1.11% |
| Rhenman & Partners Asset Management AB | 196,537 | $936,000 | 0.28% |
| FORTALEZA ASSET MANAGEMENT INC/ | 78,055 | $372,000 | 0.19% |
| Baker Brothers Advisors | 1,826,358 | $8,693,000 | 0.11% |
| Rotella Capital Management, Inc. | 14,600 | $69,000 | 0.08% |
| FRANKLIN STREET ADVISORS INC /NC | 69,700 | $332,000 | 0.07% |
| FEDERATED HERMES, INC. | 3,036,963 | $14,456,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 160,000 | $760,000 | 0.04% |
| SMITH ASSET MANAGEMENT GROUP LP | 200,118 | $953,000 | 0.04% |
| Princeton Alpha Management LP | 22,329 | $106,000 | 0.03% |